We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




World’s First Gastroscope with 4.2 MM Working Channel Helps Access Difficult-to-Reach Anatomical Areas

By HospiMedica International staff writers
Posted on 18 Sep 2023
Print article
Image: Ambu has received CE mark for its therapeutic gastroscope with a large 4.2mm working channel (Photo courtesy of Ambu)
Image: Ambu has received CE mark for its therapeutic gastroscope with a large 4.2mm working channel (Photo courtesy of Ambu)

The world’s first gastroscope featuring a 4.2 mm working channel provides gastroenterologists with a powerful suction performance during procedures conducted in the ICU and endoscopy unit.

Ambu’s (Ballerup, Denmark) aScope Gastro Large is the world’s first gastroscope with a 4.2 mm working channel as well as the first endoscope to be manufactured using bioplastic materials. The larger-sized gastroscopy solution, which comprises the Ambu aScope Gastro Large and Ambu aBox 2, has been built and tested in collaboration with foremost gastroenterology experts. As the world’s first gastroscope with a 4.2 mm working channel, it allows gastroenterologists to experience the required powerful suction performance of a therapeutic gastroscope, while also providing the maneuverability and precision of a standard gastroscope, enabling access to difficult-to-reach anatomical areas.

In comparison to the latest 3.7 mm therapeutic gastroscope available, the working channel of the Ambu aScope Gastro Large delivers a significantly stronger suction performance, both when used with or without other tools. This makes it a crucial instrument for conducting a variety of upper GI procedures in both ICU and endoscopy units, including managing bleeds, conducting necrosectomies, and placing stents. These procedures typically demand both a broad working channel and strong suction capabilities. The system, further supported by Ambu's aBox 2, offers a single-use solution that combines portability and convenience with the power of Ambu's software ecosystem, which is also compatible with the company’s other endoscope products. As the world’s first endoscope manufactured with bioplastic materials, the Ambu aScope Gastro Large features a scope handle made of material derived from second-generation feedstock, e.g., recycled food waste, ensuring a notably lower carbon footprint. Ambu has launched the Ambu aScope Gastro Large and Ambu aBox 2 in Europe, thereby expanding the company’s offering in gastroenterology.

"As a single-use endoscopy company, we believe that applying sustainable practices is both an obligation and an opportunity to lead by example,” said Britt Meelby Jensen, Chief Executive Officer of Ambu. “Being the first company in the world to bring an endoscope made with bioplastics to customers is not only a milestone for Ambu – it is a significant step forward within the industry, on the road to positive change."

Related Links:
Ambu

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Compact C-Arm
Arcovis DRF-C S21

Print article

Channels

Critical Care

view channel
Image: The new risk assessment tool determines patient-specific risks of developing unfavorable outcomes with heart failure (Photo courtesy of 123RF)

Powerful AI Risk Assessment Tool Predicts Outcomes in Heart Failure Patients

Heart failure is a serious condition where the heart cannot pump sufficient blood to meet the body's needs, leading to symptoms like fatigue, weakness, and swelling in the legs and feet, and it can ultimately... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.